Biogen
Corporate Social Responsibility (CSR), Sustainability and Cause News & Media
Biogen
Videos
Flexible Media Releases
Nov 16, 2020 11:05 AM ET


Nov 12, 2020 1:30 PM ET



Sep 17, 2020 2:15 PM ET


Sep 14, 2020 12:30 PM ET



Pages


Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Biogen has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing research programs in multiple sclerosis and neuroimmunology, Alzheimer’s disease and dementia, neuromuscular disorders, movement disorders, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain.